Capital Guardian Trust’s Integra LifeSciences IART Stock Holding History

Capital Guardian Trust’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$9.6M	Sell	171,809 -8,341	-5%	-$430K	0.13%	134
2019 Q1	$10M	Buy	180,150 +40,546	+29%	+$2.07M	0.13%	127
2018 Q4	$6.3M	Buy	139,604 +10,109	+8%	+$555K	0.1%	137
2018 Q3	$8.53M	Buy	129,495 +43,761	+51%	+$2.72M	0.12%	132
2018 Q2	$5.52M	Buy	85,734 +26,216	+44%	+$1.62M	0.08%	139
2018 Q1	$3.29M	Buy	+59,518	New	+$3.12M	0.05%	167

Other funds holding IART

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Guardian Trust's IART Position: Q2 2019 in Review

Capital Guardian Trust reduced its Integra LifeSciences (IART) stake by 4.6% in Q2 2019, selling an estimated $430K and leaving 171,809 shares worth $9.6M. The position accounts for 0.13% of the portfolio, ranked #134.

Capital Guardian Trust first reported a position in IART in Q1 2018 and has held it in 6 quarters since. The position peaked at $10M in Q1 2019. 262 funds tracked by Wall St. Rank hold IART as of Q2 2019.

Capital Guardian Trust held 171,809 shares of Integra LifeSciences worth $9.6M as of Q2 2019.
Capital Guardian Trust sold 8,341 Integra LifeSciences shares in Q2 2019, an estimated $430K.
Integra LifeSciences made up 0.13% of Capital Guardian Trust's portfolio in Q2 2019, its #134 holding.
Capital Guardian Trust first reported a position in Integra LifeSciences in Q1 2018 and has held it in 6 quarters since.
Capital Guardian Trust's Integra LifeSciences position peaked at $10M in Q1 2019.
262 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2019.

Based on Capital Guardian Trust's 13F filing for Q2 2019, filed 14 Aug 2019.